MD-reviewed ·  Healthcare editorial
MedAI Verdict
Drug info

Reference AS-064  ·  AI Drug Information

Insilico Medicine Pharma.AI

by Insilico Medicine  ·  HK

End-to-end generative AI drug discovery platform.

Visit Insilico Medicine Pharma.AIRead our methodology

At a glance

Pricing
Enterprise ($500K-$2M setup, $2-7M/yr).
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
—
HQ
HK

Independent score  ·  By our public rubric

12/100Tracked
How it’s computed →
  • Regulatory & Compliance
    0/22

    No FDA clearance listed

  • Clinical Integration
    0/26

    No EHR integrations listed

  • Evidence Strength
    0/27

    No peer-reviewed coverage

  • Vendor & Market
    10.9/21.6

    market_relevance=80 (mid-tier funding/adoption)

  • Sentiment & Transparency
    3/15

    1 pricing tier(s) but no $ amounts (contact-sales pattern)

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance0/12

    No FDA clearance listed

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/14

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/4

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/21

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/6

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal11/16

    market_relevance=80 (mid-tier funding/adoption)

  • Years in market0/6

    Founded year not recorded

Sentiment & Transparency

  • Clinician sentiment (Reddit)0/9

    No clinician sentiment data available

  • Pricing transparency3/6

    1 pricing tier(s) but no $ amounts (contact-sales pattern)

Last computed May 26, 2026 · Rubric v1.0.0

Bottom line

End-to-end generative AI drug discovery platform.

Free tier available.

Editorial review pending

We do not yet have enough independent sources for Insilico Medicine Pharma.AI to publish a full editorial review. A complete review requires peer-reviewed coverage, clinician sentiment from public forums, or hands-on testing notes from our editorial team.

The vendor overview below reflects what we have verified from the vendor and from our category-level reporting. When additional sources surface, the review is regenerated automatically and dated. If you have direct hands-on experience and want to share it on the record, write to editorial@medaiverdict.com.

Overview

Chemistry42, PandaOmics. INS018_055 in trials. Generative drug discovery.

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

TierMonthlyAnnualNotes
Plan——Enterprise ($500K-$2M setup, $2-7M/yr).

Source: vendor pricing page. Verified June 4, 2026.

In the same category

Other drug info

See the full drug info ranking